SARS-CoV-2 mRNA vaccination induces an intranasal mucosal response characterized by neutralizing antibodies
Description
CONCLUSION: SARS-CoV-2 mRNA vaccination induces a robust systemic and intranasal antibody production with neutralizing capacity. Spikevax vaccinations elicit a greater antibody response than does Comirnaty vaccination systemically and intranasally.
